nodes	percent_of_prediction	percent_of_DWPC	metapath
Nimodipine—NR3C2—Prednisolone—chronic obstructive pulmonary disease	0.43	0.674	CbGbCtD
Nimodipine—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0588	0.092	CbGbCtD
Nimodipine—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0397	0.0621	CbGbCtD
Nimodipine—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0379	0.0593	CbGbCtD
Nimodipine—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0337	0.0528	CbGbCtD
Nimodipine—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0198	0.031	CbGbCtD
Nimodipine—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0187	0.0293	CbGbCtD
Nimodipine—Gastrointestinal symptom NOS—Salbutamol—chronic obstructive pulmonary disease	0.00395	0.0213	CcSEcCtD
Nimodipine—CACNB3—bronchus—chronic obstructive pulmonary disease	0.00388	0.0856	CbGeAlD
Nimodipine—CACNB3—trachea—chronic obstructive pulmonary disease	0.00348	0.0768	CbGeAlD
Nimodipine—Ileus—Salbutamol—chronic obstructive pulmonary disease	0.00328	0.0177	CcSEcCtD
Nimodipine—CACNB4—lung—chronic obstructive pulmonary disease	0.00327	0.0721	CbGeAlD
Nimodipine—Lightheadedness—Aminophylline—chronic obstructive pulmonary disease	0.00289	0.0156	CcSEcCtD
Nimodipine—AHR—bronchus—chronic obstructive pulmonary disease	0.00287	0.0634	CbGeAlD
Nimodipine—AHR—smooth muscle tissue—chronic obstructive pulmonary disease	0.00281	0.062	CbGeAlD
Nimodipine—Phlebitis—Aminophylline—chronic obstructive pulmonary disease	0.00272	0.0147	CcSEcCtD
Nimodipine—Depression—Roflumilast—chronic obstructive pulmonary disease	0.0027	0.0146	CcSEcCtD
Nimodipine—AHR—trachea—chronic obstructive pulmonary disease	0.00258	0.0569	CbGeAlD
Nimodipine—Hepatobiliary disease—Roflumilast—chronic obstructive pulmonary disease	0.00256	0.0138	CcSEcCtD
Nimodipine—CACNA1C—respiratory system—chronic obstructive pulmonary disease	0.00255	0.0564	CbGeAlD
Nimodipine—CACNB3—lung—chronic obstructive pulmonary disease	0.0025	0.0552	CbGeAlD
Nimodipine—Wheezing—Montelukast—chronic obstructive pulmonary disease	0.00234	0.0126	CcSEcCtD
Nimodipine—Cardiac disorder—Roflumilast—chronic obstructive pulmonary disease	0.00226	0.0122	CcSEcCtD
Nimodipine—Wheezing—Salbutamol—chronic obstructive pulmonary disease	0.00226	0.0122	CcSEcCtD
Nimodipine—CACNA1C—connective tissue—chronic obstructive pulmonary disease	0.00225	0.0496	CbGeAlD
Nimodipine—Immune system disorder—Roflumilast—chronic obstructive pulmonary disease	0.0022	0.0119	CcSEcCtD
Nimodipine—Lightheadedness—Salbutamol—chronic obstructive pulmonary disease	0.00208	0.0112	CcSEcCtD
Nimodipine—CACNA1C—smooth muscle tissue—chronic obstructive pulmonary disease	0.00206	0.0454	CbGeAlD
Nimodipine—NR3C2—connective tissue—chronic obstructive pulmonary disease	0.00205	0.0452	CbGeAlD
Nimodipine—Muscle spasms—Roflumilast—chronic obstructive pulmonary disease	0.00204	0.011	CcSEcCtD
Nimodipine—Cardiac failure congestive—Arformoterol—chronic obstructive pulmonary disease	0.00197	0.0106	CcSEcCtD
Nimodipine—Cardiac failure congestive—Formoterol—chronic obstructive pulmonary disease	0.00197	0.0106	CcSEcCtD
Nimodipine—NR3C2—bronchus—chronic obstructive pulmonary disease	0.00191	0.0422	CbGeAlD
Nimodipine—NR3C2—smooth muscle tissue—chronic obstructive pulmonary disease	0.00187	0.0413	CbGeAlD
Nimodipine—Palpitations—Roflumilast—chronic obstructive pulmonary disease	0.00187	0.0101	CcSEcCtD
Nimodipine—AHR—lung—chronic obstructive pulmonary disease	0.00185	0.0409	CbGeAlD
Nimodipine—Myalgia—Roflumilast—chronic obstructive pulmonary disease	0.0018	0.00973	CcSEcCtD
Nimodipine—NR3C2—trachea—chronic obstructive pulmonary disease	0.00172	0.0379	CbGeAlD
Nimodipine—Nervous system disorder—Roflumilast—chronic obstructive pulmonary disease	0.0017	0.00915	CcSEcCtD
Nimodipine—CACNB2—lung—chronic obstructive pulmonary disease	0.00168	0.0371	CbGeAlD
Nimodipine—Cramp muscle—Arformoterol—chronic obstructive pulmonary disease	0.00161	0.00867	CcSEcCtD
Nimodipine—Cramp muscle—Formoterol—chronic obstructive pulmonary disease	0.00161	0.00867	CcSEcCtD
Nimodipine—Acne—Prednisolone—chronic obstructive pulmonary disease	0.00158	0.00854	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Roflumilast—chronic obstructive pulmonary disease	0.00157	0.0085	CcSEcCtD
Nimodipine—Cramp muscle—Montelukast—chronic obstructive pulmonary disease	0.00157	0.00849	CcSEcCtD
Nimodipine—Alanine aminotransferase increased—Montelukast—chronic obstructive pulmonary disease	0.00154	0.00832	CcSEcCtD
Nimodipine—Cramp muscle—Salbutamol—chronic obstructive pulmonary disease	0.00152	0.00819	CcSEcCtD
Nimodipine—Flushing—Aminophylline—chronic obstructive pulmonary disease	0.00151	0.00812	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Roflumilast—chronic obstructive pulmonary disease	0.00149	0.00805	CcSEcCtD
Nimodipine—CACNA1D—lung—chronic obstructive pulmonary disease	0.00147	0.0324	CbGeAlD
Nimodipine—Sweating increased—Salbutamol—chronic obstructive pulmonary disease	0.00142	0.00766	CcSEcCtD
Nimodipine—Angiopathy—Tiotropium—chronic obstructive pulmonary disease	0.00139	0.00749	CcSEcCtD
Nimodipine—Immune system disorder—Tiotropium—chronic obstructive pulmonary disease	0.00138	0.00746	CcSEcCtD
Nimodipine—CACNA1C—lung—chronic obstructive pulmonary disease	0.00136	0.0299	CbGeAlD
Nimodipine—Jaundice—Montelukast—chronic obstructive pulmonary disease	0.00131	0.00709	CcSEcCtD
Nimodipine—Hepatobiliary disease—Montelukast—chronic obstructive pulmonary disease	0.00127	0.00688	CcSEcCtD
Nimodipine—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.00127	0.00687	CcSEcCtD
Nimodipine—Jaundice—Salbutamol—chronic obstructive pulmonary disease	0.00127	0.00683	CcSEcCtD
Nimodipine—Fluid retention—Prednisolone—chronic obstructive pulmonary disease	0.00126	0.00682	CcSEcCtD
Nimodipine—CYP3A5—respiratory system—chronic obstructive pulmonary disease	0.00126	0.0277	CbGeAlD
Nimodipine—Palpitations—Aminophylline—chronic obstructive pulmonary disease	0.00125	0.00673	CcSEcCtD
Nimodipine—NR3C2—lung—chronic obstructive pulmonary disease	0.00123	0.0272	CbGeAlD
Nimodipine—Hepatitis—Montelukast—chronic obstructive pulmonary disease	0.00121	0.00653	CcSEcCtD
Nimodipine—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.00118	0.00638	CcSEcCtD
Nimodipine—Palpitations—Tiotropium—chronic obstructive pulmonary disease	0.00118	0.00635	CcSEcCtD
Nimodipine—Acne—Prednisone—chronic obstructive pulmonary disease	0.00115	0.00621	CcSEcCtD
Nimodipine—Hypertension—Tiotropium—chronic obstructive pulmonary disease	0.00115	0.0062	CcSEcCtD
Nimodipine—Cardiac disorder—Formoterol—chronic obstructive pulmonary disease	0.00115	0.00618	CcSEcCtD
Nimodipine—Cardiac disorder—Arformoterol—chronic obstructive pulmonary disease	0.00115	0.00618	CcSEcCtD
Nimodipine—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.00114	0.00617	CcSEcCtD
Nimodipine—Myalgia—Tiotropium—chronic obstructive pulmonary disease	0.00113	0.00612	CcSEcCtD
Nimodipine—Nervous system disorder—Aminophylline—chronic obstructive pulmonary disease	0.00113	0.0061	CcSEcCtD
Nimodipine—Tachycardia—Aminophylline—chronic obstructive pulmonary disease	0.00113	0.00607	CcSEcCtD
Nimodipine—Cardiac disorder—Montelukast—chronic obstructive pulmonary disease	0.00112	0.00606	CcSEcCtD
Nimodipine—Immune system disorder—Formoterol—chronic obstructive pulmonary disease	0.00112	0.00602	CcSEcCtD
Nimodipine—Immune system disorder—Arformoterol—chronic obstructive pulmonary disease	0.00112	0.00602	CcSEcCtD
Nimodipine—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.0011	0.00593	CcSEcCtD
Nimodipine—Immune system disorder—Montelukast—chronic obstructive pulmonary disease	0.00109	0.00589	CcSEcCtD
Nimodipine—Rash—Roflumilast—chronic obstructive pulmonary disease	0.00109	0.00588	CcSEcCtD
Nimodipine—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.00109	0.00588	CcSEcCtD
Nimodipine—Clevidipine—CYP1A2—chronic obstructive pulmonary disease	0.00109	0.171	CrCbGaD
Nimodipine—Oedema—Tiotropium—chronic obstructive pulmonary disease	0.00109	0.00587	CcSEcCtD
Nimodipine—Headache—Roflumilast—chronic obstructive pulmonary disease	0.00108	0.00584	CcSEcCtD
Nimodipine—Cardiac disorder—Salbutamol—chronic obstructive pulmonary disease	0.00108	0.00584	CcSEcCtD
Nimodipine—Flushing—Salbutamol—chronic obstructive pulmonary disease	0.00108	0.00584	CcSEcCtD
Nimodipine—Hypotension—Aminophylline—chronic obstructive pulmonary disease	0.00108	0.00581	CcSEcCtD
Nimodipine—Nervous system disorder—Tiotropium—chronic obstructive pulmonary disease	0.00107	0.00575	CcSEcCtD
Nimodipine—Cardiac failure congestive—Prednisolone—chronic obstructive pulmonary disease	0.00107	0.00575	CcSEcCtD
Nimodipine—Tachycardia—Tiotropium—chronic obstructive pulmonary disease	0.00106	0.00572	CcSEcCtD
Nimodipine—Angiopathy—Salbutamol—chronic obstructive pulmonary disease	0.00106	0.00571	CcSEcCtD
Nimodipine—Immune system disorder—Salbutamol—chronic obstructive pulmonary disease	0.00105	0.00568	CcSEcCtD
Nimodipine—Nisoldipine—CYP1A2—chronic obstructive pulmonary disease	0.00104	0.164	CrCbGaD
Nimodipine—Muscle spasms—Formoterol—chronic obstructive pulmonary disease	0.00103	0.00558	CcSEcCtD
Nimodipine—Muscle spasms—Arformoterol—chronic obstructive pulmonary disease	0.00103	0.00558	CcSEcCtD
Nimodipine—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.00103	0.00554	CcSEcCtD
Nimodipine—Muscle spasms—Montelukast—chronic obstructive pulmonary disease	0.00101	0.00546	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.00099	0.00534	CcSEcCtD
Nimodipine—Nilvadipine—CYP1A2—chronic obstructive pulmonary disease	0.000976	0.154	CrCbGaD
Nimodipine—Muscle spasms—Salbutamol—chronic obstructive pulmonary disease	0.000976	0.00527	CcSEcCtD
Nimodipine—Palpitations—Formoterol—chronic obstructive pulmonary disease	0.00095	0.00513	CcSEcCtD
Nimodipine—Palpitations—Arformoterol—chronic obstructive pulmonary disease	0.00095	0.00513	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.000939	0.00506	CcSEcCtD
Nimodipine—Palpitations—Montelukast—chronic obstructive pulmonary disease	0.000931	0.00502	CcSEcCtD
Nimodipine—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.000928	0.00501	CcSEcCtD
Nimodipine—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.000928	0.00501	CcSEcCtD
Nimodipine—Fluid retention—Prednisone—chronic obstructive pulmonary disease	0.000919	0.00496	CcSEcCtD
Nimodipine—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.000915	0.00494	CcSEcCtD
Nimodipine—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.000915	0.00494	CcSEcCtD
Nimodipine—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.000897	0.00484	CcSEcCtD
Nimodipine—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.000896	0.00484	CcSEcCtD
Nimodipine—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000877	0.00473	CcSEcCtD
Nimodipine—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000877	0.00473	CcSEcCtD
Nimodipine—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.000876	0.00473	CcSEcCtD
Nimodipine—Amlodipine—CYP1A1—chronic obstructive pulmonary disease	0.000872	0.137	CrCbGaD
Nimodipine—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000864	0.00466	CcSEcCtD
Nimodipine—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.00086	0.00464	CcSEcCtD
Nimodipine—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.00086	0.00464	CcSEcCtD
Nimodipine—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000859	0.00464	CcSEcCtD
Nimodipine—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000856	0.00462	CcSEcCtD
Nimodipine—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000856	0.00462	CcSEcCtD
Nimodipine—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000849	0.00458	CcSEcCtD
Nimodipine—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000843	0.00455	CcSEcCtD
Nimodipine—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000841	0.00454	CcSEcCtD
Nimodipine—Amlodipine—CYP1A2—chronic obstructive pulmonary disease	0.000841	0.132	CrCbGaD
Nimodipine—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000828	0.00447	CcSEcCtD
Nimodipine—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.00082	0.00442	CcSEcCtD
Nimodipine—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.00082	0.00442	CcSEcCtD
Nimodipine—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000816	0.0044	CcSEcCtD
Nimodipine—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	0.000814	0.00439	CcSEcCtD
Nimodipine—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000812	0.00438	CcSEcCtD
Nimodipine—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000809	0.00436	CcSEcCtD
Nimodipine—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000801	0.00432	CcSEcCtD
Nimodipine—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000801	0.00432	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000799	0.00431	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000799	0.00431	CcSEcCtD
Nimodipine—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000789	0.00426	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000783	0.00422	CcSEcCtD
Nimodipine—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000782	0.00422	CcSEcCtD
Nimodipine—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000782	0.00422	CcSEcCtD
Nimodipine—Nifedipine—CYP1A1—chronic obstructive pulmonary disease	0.000779	0.123	CrCbGaD
Nimodipine—Cardiac failure congestive—Prednisone—chronic obstructive pulmonary disease	0.000775	0.00418	CcSEcCtD
Nimodipine—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000774	0.00418	CcSEcCtD
Nimodipine—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000769	0.00415	CcSEcCtD
Nimodipine—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000762	0.00411	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000757	0.00409	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000757	0.00409	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000755	0.00407	CcSEcCtD
Nimodipine—Nifedipine—CYP1A2—chronic obstructive pulmonary disease	0.000752	0.118	CrCbGaD
Nimodipine—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000742	0.004	CcSEcCtD
Nimodipine—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000739	0.00398	CcSEcCtD
Nimodipine—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000733	0.00395	CcSEcCtD
Nimodipine—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000727	0.00392	CcSEcCtD
Nimodipine—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000726	0.00392	CcSEcCtD
Nimodipine—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000722	0.0039	CcSEcCtD
Nimodipine—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000719	0.00388	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000715	0.00386	CcSEcCtD
Nimodipine—Gastrointestinal haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000703	0.00379	CcSEcCtD
Nimodipine—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000691	0.00373	CcSEcCtD
Nimodipine—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000685	0.0037	CcSEcCtD
Nimodipine—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000685	0.00369	CcSEcCtD
Nimodipine—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000685	0.00369	CcSEcCtD
Nimodipine—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000681	0.00367	CcSEcCtD
Nimodipine—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.000681	0.00367	CcSEcCtD
Nimodipine—CYP3A5—lung—chronic obstructive pulmonary disease	0.000667	0.0147	CbGeAlD
Nimodipine—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000646	0.00349	CcSEcCtD
Nimodipine—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000646	0.00349	CcSEcCtD
Nimodipine—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000646	0.00348	CcSEcCtD
Nimodipine—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000633	0.00342	CcSEcCtD
Nimodipine—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000621	0.00335	CcSEcCtD
Nimodipine—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000621	0.00335	CcSEcCtD
Nimodipine—Alanine aminotransferase increased—Prednisone—chronic obstructive pulmonary disease	0.00062	0.00334	CcSEcCtD
Nimodipine—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.00061	0.00329	CcSEcCtD
Nimodipine—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000608	0.00328	CcSEcCtD
Nimodipine—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.0006	0.00324	CcSEcCtD
Nimodipine—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.0006	0.00324	CcSEcCtD
Nimodipine—Sweating increased—Prednisone—chronic obstructive pulmonary disease	0.000591	0.00319	CcSEcCtD
Nimodipine—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000588	0.00317	CcSEcCtD
Nimodipine—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000586	0.00316	CcSEcCtD
Nimodipine—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.00058	0.00313	CcSEcCtD
Nimodipine—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.00058	0.00313	CcSEcCtD
Nimodipine—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000568	0.00307	CcSEcCtD
Nimodipine—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000567	0.00306	CcSEcCtD
Nimodipine—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000558	0.00301	CcSEcCtD
Nimodipine—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000558	0.00301	CcSEcCtD
Nimodipine—Rash—Formoterol—chronic obstructive pulmonary disease	0.000553	0.00298	CcSEcCtD
Nimodipine—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000553	0.00298	CcSEcCtD
Nimodipine—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000553	0.00298	CcSEcCtD
Nimodipine—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000553	0.00298	CcSEcCtD
Nimodipine—Headache—Formoterol—chronic obstructive pulmonary disease	0.00055	0.00297	CcSEcCtD
Nimodipine—Headache—Arformoterol—chronic obstructive pulmonary disease	0.00055	0.00297	CcSEcCtD
Nimodipine—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000548	0.00296	CcSEcCtD
Nimodipine—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000546	0.00295	CcSEcCtD
Nimodipine—Rash—Montelukast—chronic obstructive pulmonary disease	0.000542	0.00292	CcSEcCtD
Nimodipine—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000541	0.00292	CcSEcCtD
Nimodipine—Depression—Prednisone—chronic obstructive pulmonary disease	0.00054	0.00291	CcSEcCtD
Nimodipine—Headache—Montelukast—chronic obstructive pulmonary disease	0.000538	0.0029	CcSEcCtD
Nimodipine—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000527	0.00284	CcSEcCtD
Nimodipine—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000522	0.00282	CcSEcCtD
Nimodipine—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000522	0.00282	CcSEcCtD
Nimodipine—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000521	0.00281	CcSEcCtD
Nimodipine—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000521	0.00281	CcSEcCtD
Nimodipine—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000519	0.0028	CcSEcCtD
Nimodipine—Nausea—Montelukast—chronic obstructive pulmonary disease	0.00051	0.00275	CcSEcCtD
Nimodipine—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000503	0.00271	CcSEcCtD
Nimodipine—Bradycardia—Prednisone—chronic obstructive pulmonary disease	0.000495	0.00267	CcSEcCtD
Nimodipine—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000492	0.00265	CcSEcCtD
Nimodipine—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000475	0.00256	CcSEcCtD
Nimodipine—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000464	0.0025	CcSEcCtD
Nimodipine—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000459	0.00248	CcSEcCtD
Nimodipine—CYP3A4—Estrogen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000458	0.00368	CbGpPWpGaD
Nimodipine—Flushing—Prednisone—chronic obstructive pulmonary disease	0.000451	0.00243	CcSEcCtD
Nimodipine—CACNB4—NCAM signaling for neurite out-growth—IL6—chronic obstructive pulmonary disease	0.000445	0.00358	CbGpPWpGaD
Nimodipine—CACNB2—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000444	0.00357	CbGpPWpGaD
Nimodipine—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.000441	0.00238	CcSEcCtD
Nimodipine—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	0.000439	0.00237	CcSEcCtD
Nimodipine—CYP3A4—Aflatoxin activation and detoxification—CYP1A2—chronic obstructive pulmonary disease	0.000438	0.00353	CbGpPWpGaD
Nimodipine—CYP3A4—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000421	0.00339	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—APIP—chronic obstructive pulmonary disease	0.00042	0.00338	CbGpPWpGaD
Nimodipine—CACNA1D—Calcium Regulation in the Cardiac Cell—ADRB2—chronic obstructive pulmonary disease	0.000405	0.00326	CbGpPWpGaD
Nimodipine—CYP3A4—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000405	0.00326	CbGpPWpGaD
Nimodipine—CACNB4—Developmental Biology—ADIPOQ—chronic obstructive pulmonary disease	0.000393	0.00316	CbGpPWpGaD
Nimodipine—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.000391	0.00211	CcSEcCtD
Nimodipine—AHR—Circadian rythm related genes—SERPINE1—chronic obstructive pulmonary disease	0.000387	0.00311	CbGpPWpGaD
Nimodipine—CYP3A5—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000384	0.00309	CbGpPWpGaD
Nimodipine—CACNA1S—Alzheimers Disease—IL1B—chronic obstructive pulmonary disease	0.000384	0.00309	CbGpPWpGaD
Nimodipine—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000376	0.00302	CbGpPWpGaD
Nimodipine—CYP3A5—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000371	0.00298	CbGpPWpGaD
Nimodipine—CACNB3—Myometrial Relaxation and Contraction Pathways—NOS3—chronic obstructive pulmonary disease	0.000369	0.00297	CbGpPWpGaD
Nimodipine—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000365	0.00294	CbGpPWpGaD
Nimodipine—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.000365	0.00197	CcSEcCtD
Nimodipine—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.00036	0.00194	CcSEcCtD
Nimodipine—CACNA1C—Calcium Regulation in the Cardiac Cell—ADRB2—chronic obstructive pulmonary disease	0.000356	0.00286	CbGpPWpGaD
Nimodipine—CACNB3—NCAM signaling for neurite out-growth—IL6—chronic obstructive pulmonary disease	0.000356	0.00286	CbGpPWpGaD
Nimodipine—CYP3A4—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.000351	0.00282	CbGpPWpGaD
Nimodipine—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.00035	0.00189	CcSEcCtD
Nimodipine—CACNB1—NCAM signaling for neurite out-growth—IL6—chronic obstructive pulmonary disease	0.000346	0.00278	CbGpPWpGaD
Nimodipine—AHR—Adipogenesis—TGFB1—chronic obstructive pulmonary disease	0.000346	0.00278	CbGpPWpGaD
Nimodipine—Oedema—Prednisone—chronic obstructive pulmonary disease	0.000345	0.00186	CcSEcCtD
Nimodipine—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000339	0.00183	CcSEcCtD
Nimodipine—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000337	0.00182	CcSEcCtD
Nimodipine—AHR—Integrated Breast Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	0.000334	0.00269	CbGpPWpGaD
Nimodipine—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000334	0.0018	CcSEcCtD
Nimodipine—CYP3A4—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000333	0.00268	CbGpPWpGaD
Nimodipine—AHR—Adipogenesis—TNF—chronic obstructive pulmonary disease	0.000323	0.0026	CbGpPWpGaD
Nimodipine—NR3C2—Generic Transcription Pathway—CTGF—chronic obstructive pulmonary disease	0.00032	0.00258	CbGpPWpGaD
Nimodipine—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000315	0.0017	CcSEcCtD
Nimodipine—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000314	0.0017	CcSEcCtD
Nimodipine—CACNB3—Myometrial Relaxation and Contraction Pathways—IL1B—chronic obstructive pulmonary disease	0.000314	0.00253	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—ADIPOQ—chronic obstructive pulmonary disease	0.000314	0.00253	CbGpPWpGaD
Nimodipine—CACNA1D—Alzheimers Disease—IL1B—chronic obstructive pulmonary disease	0.000312	0.00251	CbGpPWpGaD
Nimodipine—CYP3A4—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000306	0.00246	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—ADIPOQ—chronic obstructive pulmonary disease	0.000305	0.00246	CbGpPWpGaD
Nimodipine—CYP3A5—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000305	0.00245	CbGpPWpGaD
Nimodipine—AHR—Integrated Breast Cancer Pathway—EGFR—chronic obstructive pulmonary disease	0.000301	0.00242	CbGpPWpGaD
Nimodipine—Rash—Prednisolone—chronic obstructive pulmonary disease	0.0003	0.00162	CcSEcCtD
Nimodipine—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000299	0.00161	CcSEcCtD
Nimodipine—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000298	0.00161	CcSEcCtD
Nimodipine—CYP3A4—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000294	0.00237	CbGpPWpGaD
Nimodipine—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000282	0.00152	CcSEcCtD
Nimodipine—CACNA1S—Alzheimers Disease—TNF—chronic obstructive pulmonary disease	0.000279	0.00224	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000278	0.00224	CbGpPWpGaD
Nimodipine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000275	0.00221	CbGpPWpGaD
Nimodipine—CACNA1C—Alzheimers Disease—IL1B—chronic obstructive pulmonary disease	0.000274	0.0022	CbGpPWpGaD
Nimodipine—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000273	0.0022	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—GC—chronic obstructive pulmonary disease	0.000271	0.00218	CbGpPWpGaD
Nimodipine—CYP3A5—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000269	0.00217	CbGpPWpGaD
Nimodipine—AHR—Adipogenesis—IL6—chronic obstructive pulmonary disease	0.000261	0.0021	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—APIP—chronic obstructive pulmonary disease	0.000257	0.00207	CbGpPWpGaD
Nimodipine—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000254	0.00137	CcSEcCtD
Nimodipine—CACNA1S—NCAM signaling for neurite out-growth—IL6—chronic obstructive pulmonary disease	0.000253	0.00204	CbGpPWpGaD
Nimodipine—AHR—Integrated Breast Cancer Pathway—TP53—chronic obstructive pulmonary disease	0.000253	0.00203	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000252	0.00203	CbGpPWpGaD
Nimodipine—CACNA1S—Alzheimers Disease—TP53—chronic obstructive pulmonary disease	0.000246	0.00198	CbGpPWpGaD
Nimodipine—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000244	0.00132	CcSEcCtD
Nimodipine—CACNB4—Developmental Biology—LEP—chronic obstructive pulmonary disease	0.000244	0.00196	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—APIP—chronic obstructive pulmonary disease	0.000243	0.00196	CbGpPWpGaD
Nimodipine—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000236	0.00127	CcSEcCtD
Nimodipine—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000228	0.00123	CcSEcCtD
Nimodipine—CACNA1D—Alzheimers Disease—TNF—chronic obstructive pulmonary disease	0.000226	0.00182	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—ADIPOQ—chronic obstructive pulmonary disease	0.000224	0.0018	CbGpPWpGaD
Nimodipine—CYP3A5—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000221	0.00178	CbGpPWpGaD
Nimodipine—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.00022	0.00118	CcSEcCtD
Nimodipine—Rash—Prednisone—chronic obstructive pulmonary disease	0.000218	0.00117	CcSEcCtD
Nimodipine—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000218	0.00117	CcSEcCtD
Nimodipine—CACNB2—NCAM signaling for neurite out-growth—IL6—chronic obstructive pulmonary disease	0.000217	0.00175	CbGpPWpGaD
Nimodipine—Headache—Prednisone—chronic obstructive pulmonary disease	0.000216	0.00117	CcSEcCtD
Nimodipine—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000216	0.00174	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—APIP—chronic obstructive pulmonary disease	0.000214	0.00172	CbGpPWpGaD
Nimodipine—CACNA1D—NCAM signaling for neurite out-growth—IL6—chronic obstructive pulmonary disease	0.000206	0.00166	CbGpPWpGaD
Nimodipine—CACNB4—Axon guidance—MMP9—chronic obstructive pulmonary disease	0.000205	0.00165	CbGpPWpGaD
Nimodipine—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000205	0.00111	CcSEcCtD
Nimodipine—AHR—Circadian rythm related genes—TP53—chronic obstructive pulmonary disease	0.000201	0.00162	CbGpPWpGaD
Nimodipine—CACNA1D—Alzheimers Disease—TP53—chronic obstructive pulmonary disease	0.000199	0.0016	CbGpPWpGaD
Nimodipine—CACNA1C—Alzheimers Disease—TNF—chronic obstructive pulmonary disease	0.000199	0.0016	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—LEP—chronic obstructive pulmonary disease	0.000195	0.00157	CbGpPWpGaD
Nimodipine—CYP3A5—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000195	0.00157	CbGpPWpGaD
Nimodipine—CYP3A5—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000192	0.00155	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—ADIPOQ—chronic obstructive pulmonary disease	0.000192	0.00154	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—LEP—chronic obstructive pulmonary disease	0.00019	0.00153	CbGpPWpGaD
Nimodipine—CACNB4—Axon guidance—VEGFA—chronic obstructive pulmonary disease	0.000184	0.00148	CbGpPWpGaD
Nimodipine—CACNB3—Myometrial Relaxation and Contraction Pathways—IL6—chronic obstructive pulmonary disease	0.000184	0.00148	CbGpPWpGaD
Nimodipine—AHR—Circadian rythm related genes—IL6—chronic obstructive pulmonary disease	0.000184	0.00148	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—ADIPOQ—chronic obstructive pulmonary disease	0.000182	0.00146	CbGpPWpGaD
Nimodipine—CACNA1C—NCAM signaling for neurite out-growth—IL6—chronic obstructive pulmonary disease	0.000181	0.00145	CbGpPWpGaD
Nimodipine—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000179	0.00144	CbGpPWpGaD
Nimodipine—CACNA1C—Alzheimers Disease—TP53—chronic obstructive pulmonary disease	0.000175	0.00141	CbGpPWpGaD
Nimodipine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000175	0.00141	CbGpPWpGaD
Nimodipine—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000172	0.00139	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.00017	0.00137	CbGpPWpGaD
Nimodipine—CACNB4—Axon guidance—EGFR—chronic obstructive pulmonary disease	0.000166	0.00134	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—GC—chronic obstructive pulmonary disease	0.000165	0.00133	CbGpPWpGaD
Nimodipine—CACNB3—Axon guidance—MMP9—chronic obstructive pulmonary disease	0.000164	0.00132	CbGpPWpGaD
Nimodipine—CYP3A5—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000162	0.0013	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000161	0.0013	CbGpPWpGaD
Nimodipine—CACNB1—Axon guidance—MMP9—chronic obstructive pulmonary disease	0.00016	0.00129	CbGpPWpGaD
Nimodipine—CYP3A5—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.00016	0.00128	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—ADIPOQ—chronic obstructive pulmonary disease	0.00016	0.00128	CbGpPWpGaD
Nimodipine—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000157	0.00126	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—GC—chronic obstructive pulmonary disease	0.000157	0.00126	CbGpPWpGaD
Nimodipine—NR3C2—Gene Expression—CTGF—chronic obstructive pulmonary disease	0.000154	0.00124	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000154	0.00124	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000148	0.00119	CbGpPWpGaD
Nimodipine—CACNB3—Axon guidance—VEGFA—chronic obstructive pulmonary disease	0.000147	0.00119	CbGpPWpGaD
Nimodipine—CACNB4—Developmental Biology—MMP9—chronic obstructive pulmonary disease	0.000147	0.00118	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000146	0.00118	CbGpPWpGaD
Nimodipine—NR3C2—Generic Transcription Pathway—SERPINE1—chronic obstructive pulmonary disease	0.000146	0.00117	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000146	0.00117	CbGpPWpGaD
Nimodipine—NR3C2—Gene Expression—HDAC2—chronic obstructive pulmonary disease	0.000144	0.00116	CbGpPWpGaD
Nimodipine—CACNB1—Axon guidance—VEGFA—chronic obstructive pulmonary disease	0.000143	0.00115	CbGpPWpGaD
Nimodipine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000142	0.00114	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000142	0.00114	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—LEP—chronic obstructive pulmonary disease	0.000139	0.00112	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—GC—chronic obstructive pulmonary disease	0.000138	0.00111	CbGpPWpGaD
Nimodipine—CYP3A5—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000135	0.00109	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000133	0.00107	CbGpPWpGaD
Nimodipine—CYP3A5—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000133	0.00107	CbGpPWpGaD
Nimodipine—CACNB3—Axon guidance—EGFR—chronic obstructive pulmonary disease	0.000133	0.00107	CbGpPWpGaD
Nimodipine—CACNB4—Developmental Biology—VEGFA—chronic obstructive pulmonary disease	0.000132	0.00106	CbGpPWpGaD
Nimodipine—CACNB1—Axon guidance—EGFR—chronic obstructive pulmonary disease	0.000129	0.00104	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000128	0.00103	CbGpPWpGaD
Nimodipine—CACNB4—Axon guidance—IL6—chronic obstructive pulmonary disease	0.000128	0.00103	CbGpPWpGaD
Nimodipine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000127	0.00102	CbGpPWpGaD
Nimodipine—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000125	0.00101	CbGpPWpGaD
Nimodipine—CYP3A5—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000124	0.000998	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000123	0.00099	CbGpPWpGaD
Nimodipine—CYP3A5—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.000122	0.000984	CbGpPWpGaD
Nimodipine—CACNB4—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	0.000121	0.000972	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—LEP—chronic obstructive pulmonary disease	0.000119	0.000959	CbGpPWpGaD
Nimodipine—CACNB4—Developmental Biology—EGFR—chronic obstructive pulmonary disease	0.000118	0.000953	CbGpPWpGaD
Nimodipine—CYP3A5—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000118	0.000946	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—MMP9—chronic obstructive pulmonary disease	0.000117	0.000943	CbGpPWpGaD
Nimodipine—CACNA1S—Axon guidance—MMP9—chronic obstructive pulmonary disease	0.000117	0.000942	CbGpPWpGaD
Nimodipine—CYP3A5—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	0.000116	0.000933	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—MMP9—chronic obstructive pulmonary disease	0.000114	0.000918	CbGpPWpGaD
Nimodipine—CACNB4—Developmental Biology—TNF—chronic obstructive pulmonary disease	0.000113	0.000908	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—LEP—chronic obstructive pulmonary disease	0.000113	0.000908	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—VEGFA—chronic obstructive pulmonary disease	0.000105	0.000847	CbGpPWpGaD
Nimodipine—CACNA1S—Axon guidance—VEGFA—chronic obstructive pulmonary disease	0.000105	0.000846	CbGpPWpGaD
Nimodipine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000103	0.000828	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000103	0.000825	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—VEGFA—chronic obstructive pulmonary disease	0.000102	0.000824	CbGpPWpGaD
Nimodipine—CACNB3—Axon guidance—IL6—chronic obstructive pulmonary disease	0.000102	0.000821	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000101	0.000814	CbGpPWpGaD
Nimodipine—CACNB2—Axon guidance—MMP9—chronic obstructive pulmonary disease	0.0001	0.000807	CbGpPWpGaD
Nimodipine—CACNB1—Axon guidance—IL6—chronic obstructive pulmonary disease	9.92e-05	0.000799	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—LEP—chronic obstructive pulmonary disease	9.91e-05	0.000798	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	9.66e-05	0.000777	CbGpPWpGaD
Nimodipine—CACNA1D—Axon guidance—MMP9—chronic obstructive pulmonary disease	9.5e-05	0.000765	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—EGFR—chronic obstructive pulmonary disease	9.47e-05	0.000762	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—APIP—chronic obstructive pulmonary disease	9.46e-05	0.000761	CbGpPWpGaD
Nimodipine—CACNA1S—Axon guidance—EGFR—chronic obstructive pulmonary disease	9.46e-05	0.000761	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—GSTM1—chronic obstructive pulmonary disease	9.43e-05	0.000759	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	9.4e-05	0.000756	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—EGFR—chronic obstructive pulmonary disease	9.21e-05	0.000741	CbGpPWpGaD
Nimodipine—CACNB4—Developmental Biology—IL6—chronic obstructive pulmonary disease	9.1e-05	0.000733	CbGpPWpGaD
Nimodipine—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	9.05e-05	0.000728	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—GSTT1—chronic obstructive pulmonary disease	9.04e-05	0.000727	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—TNF—chronic obstructive pulmonary disease	9.02e-05	0.000726	CbGpPWpGaD
Nimodipine—CACNB2—Axon guidance—VEGFA—chronic obstructive pulmonary disease	9.01e-05	0.000725	CbGpPWpGaD
Nimodipine—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	8.95e-05	0.00072	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8.94e-05	0.000719	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—GCLC—chronic obstructive pulmonary disease	8.94e-05	0.000719	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—TNF—chronic obstructive pulmonary disease	8.77e-05	0.000706	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—GSTT1—chronic obstructive pulmonary disease	8.56e-05	0.000689	CbGpPWpGaD
Nimodipine—CACNA1D—Axon guidance—VEGFA—chronic obstructive pulmonary disease	8.53e-05	0.000687	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—GCLC—chronic obstructive pulmonary disease	8.46e-05	0.000681	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—MMP9—chronic obstructive pulmonary disease	8.35e-05	0.000672	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—MMP9—chronic obstructive pulmonary disease	8.35e-05	0.000672	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—CTGF—chronic obstructive pulmonary disease	8.15e-05	0.000656	CbGpPWpGaD
Nimodipine—CACNB2—Axon guidance—EGFR—chronic obstructive pulmonary disease	8.11e-05	0.000652	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—CTGF—chronic obstructive pulmonary disease	7.72e-05	0.000621	CbGpPWpGaD
Nimodipine—CACNA1D—Axon guidance—EGFR—chronic obstructive pulmonary disease	7.68e-05	0.000618	CbGpPWpGaD
Nimodipine—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	7.52e-05	0.000605	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—GSTT1—chronic obstructive pulmonary disease	7.52e-05	0.000605	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	7.51e-05	0.000605	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—VEGFA—chronic obstructive pulmonary disease	7.5e-05	0.000603	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—VEGFA—chronic obstructive pulmonary disease	7.5e-05	0.000603	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—GCLC—chronic obstructive pulmonary disease	7.43e-05	0.000598	CbGpPWpGaD
Nimodipine—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	7.42e-05	0.000597	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—IL6—chronic obstructive pulmonary disease	7.28e-05	0.000586	CbGpPWpGaD
Nimodipine—CACNA1S—Axon guidance—IL6—chronic obstructive pulmonary disease	7.27e-05	0.000585	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—MMP9—chronic obstructive pulmonary disease	7.16e-05	0.000576	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—CYP1A2—chronic obstructive pulmonary disease	7.11e-05	0.000573	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—IL6—chronic obstructive pulmonary disease	7.08e-05	0.00057	CbGpPWpGaD
Nimodipine—NR3C2—Gene Expression—SERPINE1—chronic obstructive pulmonary disease	7.03e-05	0.000565	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	6.88e-05	0.000554	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—CTGF—chronic obstructive pulmonary disease	6.78e-05	0.000546	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—MMP9—chronic obstructive pulmonary disease	6.78e-05	0.000546	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—EGFR—chronic obstructive pulmonary disease	6.75e-05	0.000543	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—EGFR—chronic obstructive pulmonary disease	6.75e-05	0.000543	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—VEGFA—chronic obstructive pulmonary disease	6.43e-05	0.000517	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—TNF—chronic obstructive pulmonary disease	6.43e-05	0.000517	CbGpPWpGaD
Nimodipine—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	6.27e-05	0.000505	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.27e-05	0.000504	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	6.26e-05	0.000504	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—CYP1A2—chronic obstructive pulmonary disease	6.25e-05	0.000503	CbGpPWpGaD
Nimodipine—CACNB2—Axon guidance—IL6—chronic obstructive pulmonary disease	6.23e-05	0.000501	CbGpPWpGaD
Nimodipine—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	6.19e-05	0.000498	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.18e-05	0.000497	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—GC—chronic obstructive pulmonary disease	6.09e-05	0.00049	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—VEGFA—chronic obstructive pulmonary disease	6.09e-05	0.00049	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—ALB—chronic obstructive pulmonary disease	6.07e-05	0.000489	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—MMP9—chronic obstructive pulmonary disease	5.96e-05	0.000479	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.93e-05	0.000478	CbGpPWpGaD
Nimodipine—CACNA1D—Axon guidance—IL6—chronic obstructive pulmonary disease	5.9e-05	0.000475	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	5.9e-05	0.000475	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.85e-05	0.000471	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—NOS3—chronic obstructive pulmonary disease	5.81e-05	0.000468	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—EGFR—chronic obstructive pulmonary disease	5.79e-05	0.000466	CbGpPWpGaD
Nimodipine—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	5.77e-05	0.000464	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.76e-05	0.000463	CbGpPWpGaD
Nimodipine—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	5.69e-05	0.000458	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	5.67e-05	0.000456	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	5.59e-05	0.00045	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—TNF—chronic obstructive pulmonary disease	5.51e-05	0.000443	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—EGFR—chronic obstructive pulmonary disease	5.48e-05	0.000441	CbGpPWpGaD
Nimodipine—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	5.47e-05	0.00044	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.46e-05	0.000439	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.45e-05	0.000439	CbGpPWpGaD
Nimodipine—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	5.39e-05	0.000434	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—VEGFA—chronic obstructive pulmonary disease	5.35e-05	0.000431	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—TNF—chronic obstructive pulmonary disease	5.22e-05	0.00042	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.21e-05	0.00042	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—IL6—chronic obstructive pulmonary disease	5.19e-05	0.000417	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—IL6—chronic obstructive pulmonary disease	5.18e-05	0.000417	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.17e-05	0.000416	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.14e-05	0.000414	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	4.91e-05	0.000395	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—EGFR—chronic obstructive pulmonary disease	4.81e-05	0.000387	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.79e-05	0.000386	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—TNF—chronic obstructive pulmonary disease	4.58e-05	0.000369	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.54e-05	0.000366	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—IL6—chronic obstructive pulmonary disease	4.45e-05	0.000358	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	4.4e-05	0.000354	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—IL6—chronic obstructive pulmonary disease	4.21e-05	0.000339	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—ALB—chronic obstructive pulmonary disease	3.71e-05	0.000299	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—IL6—chronic obstructive pulmonary disease	3.7e-05	0.000298	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—NOS3—chronic obstructive pulmonary disease	3.55e-05	0.000286	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—ALB—chronic obstructive pulmonary disease	3.51e-05	0.000283	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—NOS3—chronic obstructive pulmonary disease	3.36e-05	0.00027	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.33e-05	0.000268	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—GCLC—chronic obstructive pulmonary disease	3.29e-05	0.000265	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—ALB—chronic obstructive pulmonary disease	3.09e-05	0.000248	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—CTGF—chronic obstructive pulmonary disease	3e-05	0.000242	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—NOS3—chronic obstructive pulmonary disease	2.95e-05	0.000238	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.91e-05	0.000234	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	2.83e-05	0.000228	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.77e-05	0.000223	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.63e-05	0.000212	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.31e-05	0.000186	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.28e-05	0.000183	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.12e-05	0.000171	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.01e-05	0.000162	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.55e-05	0.000125	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	1.53e-05	0.000123	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	1.4e-05	0.000112	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—ALB—chronic obstructive pulmonary disease	1.37e-05	0.00011	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—NOS3—chronic obstructive pulmonary disease	1.31e-05	0.000105	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.29e-05	0.000104	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.07e-05	8.63e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.06e-05	8.52e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	9.86e-06	7.93e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	9.35e-06	7.52e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	6.35e-06	5.11e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	6.08e-06	4.89e-05	CbGpPWpGaD
